Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Isis Pharmaceuticals, Inc.

Thumbshot of's website
http://www.isispharm.com

Isis Pharmaceuticals, Carlsbad California, United States of America.

Isis Pharmaceuticals, Inc. is a leading drug discovery and development company, focused exclusively on the therapeutic target, RNA. Founded in 1989, Isis' mission is to develop products from its RNA
Isis Pharmaceuticals - Company Profile

Ticker -
ISIS - Financial Information



Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity at ADA Scientific Sessions

Tuesday 9th of June 2009 7:00

BioPortfolio no longer holds the full text of this article, it is however likley to be available via the below links:

Google Custom Search
Browse other news from this organisation: Isis Pharmaceuticals, Inc.

Related Web-Links

(If any, Generated Automatically)
Google Custom Search

Source PR Newswire

PR Newswire Logo
www.prnewswire.co.uk

Browse news from 2009

Download PDF PDF Version

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.